Skip to content

dr. reddy's labs glp-1 receptor agonist Dr. Reddy's has just launched Obeda, India's first DCGI-approved generic semaglutide injection for Type 2 diabetes, at just ₹4,200/month

Marsoni M251S
Sale price$23.95
Pay 4 payments of $5.99 a month.Shop Pay
Get it in 3 business days with 1 day shipping. Friday, May 29
Real Talk: 12% of Americans report using GLP 1 medications Cardiovascular and mortality outcomes with GLP 1 receptor agonists vs other glucose lowering drugs in individuals with NAFLD and type 2 diabetes: a large population based matched cohort study Diabetologia Springer Nature Link Researchers move closer to matching patients with GLP 1 drug that works best for them Reuters The Influence of Glucagon like Peptide 1 Receptor Agonists and Other Incretin Hormone Agonists on Body Composition
Easy Shipping

Quick Dispatch:

Your dr. reddy's labs glp-1 receptor agonist Dr. Reddy's has just launched Obeda, India's first DCGI-approved generic semaglutide injection for Type 2 diabetes, at just ₹4,200/month orders ship within 1-2 business days.

Delivery Options:

  • Standard: 3-7 business days
  • Fast: 2-3 business days
  • Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your dr. reddy's labs glp-1 receptor agonist Dr. Reddy's has just launched Obeda, India's first DCGI-approved generic semaglutide injection for Type 2 diabetes, at just ₹4,200/month ships.

Need Help?
Questions about dr. reddy's labs glp-1 receptor agonist Dr. Reddy's has just launched Obeda, India's first DCGI-approved generic semaglutide injection for Type 2 diabetes, at just ₹4,200/month, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for dr. reddy's labs glp-1 receptor agonist Dr. Reddy's has just launched Obeda, India's first DCGI-approved generic semaglutide injection for Type 2 diabetes, at just ₹4,200/month in your area.

Get Shipping Estimates

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy
4.7 ★★★★★
Based on 1474 reviews
Sort
Highest Rating
Newest First
Oldest First
Product Reviews
D
Verified Purchase
Devonte Chandoo
New York, US
★★★★★ 3
Looks nice but uncomfortable
Size: 7, Color: Champagne, Size: 7, Color: Champagne
Nice tone gold ,can’t stay in it all night not so comfortable, start to burn in between your toes ,true to size for the price could be a little more comfortable
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 23, 2026
K
Verified Purchase
Katherine
Alexandria, US
★★★★★ 2
Very uncomfortable
Size: 7, Color: Brown Patent
Most uncomfortable shoes I own. The middle part is so hard and digs into your toes making it really painful. I wear a lot of heels and never have I had a pair that hurt this bad.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on March 23, 2026
L
Verified Purchase
Leesy McCorgary
Dallas, US
★★★★★ 5
Great fit!
Size: 6.5, Color: Champagne
Great fit! Cute and comfortable.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on September 30, 2025
A
Verified Purchase
Antonia McNeil
Chelsea, US
★★★★★ 5
Foxxy Black Heel
Size: 6.5, Color: Black Patent
10/10 recommend. I love Steve Madden shoes. These were actually comfortable. I love the style and quality. The height was perfect for me. I was turning heads. The gold buckle and solid black made the heel pop!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on March 25, 2026
S
Verified Purchase
ShawNae
Carnegie, US
★★★★★ 4
Heel girly
Size: 8, Color: Burgundy Patent, Size: 8, Color: Burgundy Patent
The bottom is very slippery and you need cushions to go at the bottom of them. You have to be a real heel girly to walk in them, slightly comfortable.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 13, 2026

recommand products